2013 World Symposium on PH CTEPH Diagnosisa

2013 World Symposium on PH (cont) CTEPH Treatmenta

Riociguat in Inoperable or Residual CTEPH and PAH

Switching Therapy in CTEPH and PAH

Switching Therapy in CTEPH and PAH (cont)

Case Presentation A PAH Patient With Worsening Symptoms on ERA

Initial Improvement With Bosentan Therapy

At 2 Years Decreased Exercise Capacity, FC, and Right Ventricular Function

Physical Examination

Current Prognostic Evaluation

RHC Frequency Recommendationsa,b

Recommended Treatment Goals

Riociguat in PAH PATENT-1 Trial

Riociguat Efficacy Secondary End Points

Other Combination Therapy Options

Switching Therapy Follow-up Recommendations

Individualizing Treatment With Riociguat

Individualizing Treatment With Riociguat (cont)

Case Presentation Riociguat Treatment 3-Month Follow-Up

CTEPH and PAH Importance of Proper Diagnosis

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)